Safety and Immunogenicity of a Meningococcal (Groups A, C, Y, W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Children Aged 2 to 10 Years in Chile

被引：5
|
作者：
Lagos, Rosanna [1 ]
Papa, Thomas [2 ]
Munoz, Alma
Ryall, Robert [2 ]
Pina, Miriam [2 ]
Bassily, Ehab [2 ]
机构：
[1] Hosp Ninos Roberto Rio, Ctr Vacunas Desarrollo Chile, Santiago, Chile
[2] Sanofi Pasteur Inc, Swiftwater, PA USA
来源：
HUMAN VACCINES | 2005年 / 1卷 / 06期
关键词：
meningococcal disease; vaccine; immunogenicity; children; conjugate vaccine;
D O I：
10.4161/hv.1.6.2301
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Immune responses to meningococcal conjugate (Menactra (TM); MCV-4) and plain polysaccharide (Menomune (R)-A/C/Y/W-135; PSV-4) vaccines against serogroups A, C, Y, and W-135 were assessed in 220 of 1037 Chilean children aged 2 to 10 years participating in a comparative safety trial. Both vaccines were generally well tolerated. Geometric mean serum bactericidal antibody (SBA) titers 28 days postvaccination were comparable in both groups for all four serogroups. Seroconversion was evident in > 97% of MCV-4 and > 90% of PSV-4 vaccinees who tested seronegative at baseline. Menactra (TM) safely induced broad and robust immune responses against serogroups A, C, Y and W-135 in this population.
引用
收藏
页码：228 / 231
页数：4
相关论文
共 50 条
  • [21] Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2–10-year-old children: results of an open, randomised, controlled study
    Markus Knuf
    Olivier Romain
    Klaus Kindler
    Uta Walther
    Phu-My Tran
    Heidemarie Pankow-Culot
    Thomas Fischbach
    Dorothee Kieninger-Baum
    Véronique Bianco
    Yaela Baine
    Jacqueline Miller
    [J]. European Journal of Pediatrics, 2013, 172 : 601 - 612
  • [22] Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled study
    Knuf, Markus
    Romain, Olivier
    Kindler, Klaus
    Walther, Uta
    Tran, Phu-My
    Pankow-Culot, Heidemarie
    Fischbach, Thomas
    Kieninger-Baum, Dorothee
    Bianco, Veronique
    Baine, Yaela
    Miller, Jacqueline
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2013, 172 (05) : 601 - 612
  • [23] Safety and Immunogenicity of Two Doses of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Indian and Russian Children Aged 9 to 17 Months
    Javadekar, Bakul
    Ghosh, Apurba
    Kompithra, Rajeev Zachariah
    Awasthi, Shally
    Perminova, Olga
    Romanenko, Viktor
    Rodnikova, Vera
    Kharit, Susanna
    Thollot, Yael
    Bosch-Castells, Valerie
    Goldstein, Alexander
    Dubey, Himanshu
    [J]. INDIAN PEDIATRICS, 2018, 55 (12) : 1050 - 1055
  • [24] Safety and Immunogenicity of Two Doses of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Indian and Russian Children Aged 9 to 17 Months
    Bakul Javadekar
    Apurba Ghosh
    Rajeev Zachariah Kompithra
    Shally Awasthi
    Olga Perminova
    Viktor Romanenko
    Vera Rodnikova
    Susanna Kharit
    Yael Thollot
    Valerie Bosch-Castells
    Alexander Goldstein
    Himanshu Dubey
    [J]. Indian Pediatrics, 2018, 55 : 1050 - 1055
  • [25] Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers
    Vesikari, Timo
    Forsten, Aino
    Boutriau, Dominique
    Bianco, Veronique
    Van der Wielen, Marie
    Miller, Jacqueline
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (12) : 1892 - 1903
  • [26] A Randomized Trial to Assess Safety and Immunogenicity of Alternative Formulations of a Quadrivalent Meningococcal (A, C, Y, and W-135) Tetanus Protein Conjugate Vaccine in Toddlers
    McVernon, Jodie
    Nolan, Terry
    Richmond, Peter
    Reynolds, Graham
    Nissen, Michael
    Lambert, Stephen B.
    Marshall, Helen
    Papa, Thomas
    Rehm, Christine
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (01) : E15 - E23
  • [27] Immunogenicity and Safety of a Booster Dose of the 10-valent Pneumococcal Haemophilus Influenzae Protein D Conjugate Vaccine Coadministered With the Tetravalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine in Toddlers: A Randomized Trial
    Ruiz-Palacios, Guillermo M.
    Huang, Li-Min
    Lin, Tzou-Yien
    Hernandez, Lorena
    Guerrero, M. Lourdes
    Villalobos, Antonio Lavalle
    Van der Wielen, Marie
    Moreira, Marta
    Fissette, Laurence
    Borys, Dorota
    Miller, Jacqueline M.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (01) : 62 - 71
  • [28] Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial
    Dbaibo, Ghassan
    El-Ayoubi, Nabil
    Ghanem, Soha
    Hajar, Farah
    Bianco, Veronique
    Miller, Jacqueline M.
    Mesaros, Narcisa
    [J]. DRUGS & AGING, 2013, 30 (05) : 309 - 319
  • [29] VaccinesHyperhaemolysis (first reports with meningococcal vaccine groups A C Y W-135 polysaccharide and Hib vaccine conjugate) in an EBV-infected patient: case report
    [J]. Reactions Weekly, 2009, 1278 (1) : 29 - 30
  • [30] Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial
    Ghassan Dbaibo
    Nabil El-Ayoubi
    Soha Ghanem
    Farah Hajar
    Veronique Bianco
    Jacqueline M. Miller
    Narcisa Mesaros
    [J]. Drugs & Aging, 2013, 30 : 309 - 319
12345